"
Home Page1 Page2 Page3 Page4 Page5 Page6 Page7 Page8 Page9 Page10 Page11 Page12 Page13 Page14 Page15 Page16 Page17 Page18 Page19 Page20 Page21 Page22 Page23 Page24 Page25 Page26 Page27 Page28 Page29 Page30 Page31 Page32 Page33 Page34 Page35 Page36 Page37 Page38 Page39 Page40 Page41 Page42 Page43 Page44 Page45 Page46 Page47 Page48 Page49 Page50 Page51 Page52 Page53 Page54 Page55 Page56 Page57 Page58 Page59 Page60 Page61 Page62 Page63 Page64 Page65 Page66 Page67 Page68 Page69 Page70 Page71 Page72 Page73 Page74 Page75 Page76 Page77 Page78 Page79 Page80 Page81 Page82 Page83 Page84 Page85 Page86 Page87 Page88 Page89 Page90 Page91 Page92 Page93 Page94 Page95 Page96 Page97 Page98 Page99 Page100 Page101 Page102 Page103 Page104 Page105 Page106 Page107 Page108 Page109 Page110 Page111 Page112 Page113 Page114 Page115 Page116 Page117 Page118 Page119 Page120 Page121 Page122 Page123 Page124 Page125 Page126 Page127 Page128 Page129 Page130 Page131

Classification of Antitubercular Drugs

Antitubercular drugs are categorized into two main classes:

  • First-Line Drugs: High efficacy and lower toxicity. Includes Isoniazid, Rifampicin, Pyrazinamide, Ethambutol, and Streptomycin.
  • Second-Line Drugs: Used in cases of resistance or multidrug-resistant TB. Includes Ethionamide, Cycloserine, Capreomycin, Kanamycin, Amikacin, and Fluoroquinolones (e.g., Levofloxacin, Moxifloxacin).

Mechanisms of Action, Adverse Effects, and Contraindications

First-Line Drugs

Isoniazid (INH)

  • Mechanism of Action: Inhibits mycolic acid synthesis, affecting the mycobacterial cell wall.
  • Adverse Effects: Hepatotoxicity, peripheral neuropathy, hypersensitivity.
  • Contraindications: Liver disease, hypersensitivity to INH.

Rifampicin

  • Mechanism of Action: Inhibits RNA synthesis by blocking DNA-dependent RNA polymerase.
  • Adverse Effects: Hepatotoxicity, orange discoloration of body fluids, gastrointestinal disturbances.
  • Contraindications: Liver disease, certain antiretroviral drug interactions.

Pyrazinamide

  • Mechanism of Action: Lowers pH inside bacterial cells, disrupting metabolism.
  • Adverse Effects: Hepatotoxicity, hyperuricemia (may cause gout), gastrointestinal disturbances.
  • Contraindications: Severe liver disease, acute gout.

Ethambutol

  • Mechanism of Action: Inhibits arabinosyl transferase, affecting cell wall synthesis.
  • Adverse Effects: Optic neuritis, peripheral neuropathy.
  • Contraindications: Optic neuritis, young children.

Streptomycin

  • Mechanism of Action: Binds to the 30S ribosomal subunit, inhibiting protein synthesis.
  • Adverse Effects: Ototoxicity, nephrotoxicity, hypersensitivity.
  • Contraindications: Renal impairment, pregnancy, pre-existing hearing loss.

Second-Line Drugs

Ethionamide

  • Mechanism of Action: Similar to INH; inhibits mycolic acid synthesis.
  • Adverse Effects: Gastrointestinal disturbances, hepatotoxicity, peripheral neuropathy.
  • Contraindications: Liver disease, severe gastrointestinal disorders.

Cycloserine

  • Mechanism of Action: Inhibits cell wall synthesis by affecting D-alanine incorporation.
  • Adverse Effects: Neurological effects (e.g., anxiety, psychosis, seizures).
  • Contraindications: Epilepsy, severe mental disorders.

Capreomycin

  • Mechanism of Action: Disrupts protein synthesis by binding to bacterial ribosomes.
  • Adverse Effects: Nephrotoxicity, ototoxicity.
  • Contraindications: Renal impairment, hearing impairment.

Fluoroquinolones (e.g., Levofloxacin, Moxifloxacin)

  • Mechanism of Action: Inhibit DNA gyrase and topoisomerase IV, hindering DNA replication.
  • Adverse Effects: Tendonitis, gastrointestinal disturbances, QT prolongation.
  • Contraindications: Pregnancy, children, history of tendon disorders.

© 2024 Easy Notes on Pharmacology.
Privacy Policy | Contact Us Subscribe to our RSS feed